Nike Gets Booted From S&P 100 After Losing 80% of Its Value
Source: 247wallst.com
Nike will be removed from the S&P 100 effective September 21 after its market capitalization declined by roughly $200 billion; shares are down 75.21% over five years and 48.07% over the past 12 months. Q4 FY26 diluted EPS of $0.72 was bolstered by a $986 million tariff-recovery benefit, with underlying EPS estimated at $0.20 versus $0.13 consensus; FY26 revenue fell to $46.4 billion from $51.4 billion in FY24. Greater China Q4 revenue declined 17%, Nike Digital fell 12%, and management guided FY27 revenue down low- to mid-single digits as consensus FY27 EPS has fallen to $1.72 from $1.84 over 90 days.
Analysis
The key investable issue is not the index deletion itself—S&P 100-linked passive selling should be concentrated around the rebalance and is unlikely to be durable while NKE remains in the S&P 500—but the earnings-quality gap it exposes. A turnaround cannot rerate on adjusted earnings if the core P&L is still absorbing channel cleanup, promotional intensity, and supply-chain costs; that combination leaves downside asymmetry because consensus typically de-risks revenue first and margin estimates later. The next 1-3 months should bring further estimate pressure as sell-side models incorporate management's revenue outlook, while a credible recovery requires sequential stabilization in China, digital sell-through, and gross-margin progression over multiple quarters.
ONON and DECK are not merely alternative consumer-discretionary longs: they are the likely beneficiaries if wholesale buyers continue reallocating shelf space toward faster-growing premium running brands. Their higher gross-margin structures provide more room to fund marketing and product innovation without the same earnings dilution, but both carry elevated expectations and are vulnerable to a broad footwear demand slowdown or inventory build. The contrarian case for NKE is that a lower wholesale base and reduced direct-channel mix could produce a sharp margin rebound if inventories normalize; this would falsify the short thesis if next-quarter guidance implies improving full-price sell-through and consensus FY27 EPS stops declining.
Structurally, NKE's weaker repurchase pace matters more than the headline dividend: absent meaningful buyback support, the equity is more exposed to multiple compression while operating estimates reset. Watch the September index-rebalance close for a technical dislocation, but do not confuse forced-flow weakness with a fundamental catalyst; the more material catalyst is the next earnings call's inventory, China, and gross-margin outlook.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly negative
Sentiment Score
-0.68
Ticker Sentiment
Key Decisions for Investors
- Initiate a 3-6 month pair: long ONON / short NKE, dollar-neutral and sized at 1.0-1.5% gross each. The thesis is continued share transfer and superior earnings revision breadth; target 15-20% relative outperformance, with a 7-8% relative stop if NKE guides to sequential revenue stabilization and margin expansion.
- Use any rebalance-related NKE weakness in the final 1-2 trading days before implementation only as a tactical event trade, not a standalone fundamental short entry. Cover a short-term position after the effective-date flow unless post-event analyst revisions remain negative; passive selling should fade quickly once the rebalance is complete.
- Prefer DECK over NKE for investors seeking a lower-beta footwear allocation, but wait for confirmation that HOKA growth and inventory remain intact at the next update. A deceleration in direct-to-consumer growth or gross-margin guide below plan would remove the basis for paying a premium multiple and should trigger a reassessment.
- Set an earnings watch alert on NKE: upgrade the bearish view only if management again fails to show sequential improvement in China demand, digital sell-through, and ex-one-time gross margin. Conversely, close or reduce the short if two consecutive reporting periods show positive estimate revisions and full-price sales recovery.
More News
- Paramount Skydance stock in Focus as odds of Warner Bros deal closing rise
- Morgan Stanley warns of a 7% S&P 500 dip as rebound catalysts emerge
- Truist reiterates Buy on Amer Sports stock, cites growth runway
- Stifel cuts Nike stock price target on margin, demand concerns
- Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse
- Huge News for Nike Stock Investors!
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: Sector Analysis, Improvements on Research Data, and Performance Enhancements
- Choosing an AI Copilot for Equity Research